SAN DIEGO, June 14, 2001 (PRIMEZONE) -- Chairman, President and CEO Edward F. Calesa of Women First HealthCare, Inc. (Nasdaq:WFHC) will present at the Wells Fargo Van Kasper, LLC Fourth Annual San Diego Growth Stock Conference. The conference will be held Monday, June 18, 2001 at the Wyndam Emerald Plaza Hotel in San Diego.
Mr. Calesa's presentation is scheduled from 3:30 - 4:00 p.m. Pacific Time and will include discussion of business operations, improved first quarter 2001 results, and strategic plans for the Company.
The one-day conference will focus exclusively on companies that drive the economy in the San Diego area. More than 40 public and private companies in the specialty pharmaceutical, biotechnology, consumer electronics, wireless communications, computer, software, and food industries are expected to participate.
Mr. Calesa's presentation at the Wells Fargo Van Kasper Fourth Annual San Diego Growth Stock Conference will be available to all interested parties through a live audio Webcast (with slides) on June 18, 2001, 3:30 p.m. Pacific Time, at http://servicebureau.net/servlet/IPConfServ?ORG_ID=30&CONFERENCE_ID=wellsfargovk-womenfirst. A link to the live audio Webcast will also be provided on www.womenfirst.com, Investor Relations, Interviews/Presentations. The audio Webcast will be archived for replay on the Websites for 30 days until approximately July 16. Mr. Calesa's Wells Fargo Van Kasper Fourth Annual San Diego Growth Stock Conference slide presentation will be available on the Company's Website by 3:30 p.m. Pacific Time on June 18 within the Investor Relations, Interviews/Presentations area.
About Women First HealthCare, Inc.
Founded in 1996, Women First HealthCare, Inc. is a San Diego-based specialty pharmaceutical company. Its mission is to help midlife women make informed choices regarding their health care needs and to provide pharmaceutical and lifestyle products to meet those needs. Women First is specifically targeted to women age 40+ and their clinicians. The Company's Pharmaceutical Division, which includes a nationwide team of experienced sales specialists, contacts primarily OB/GYNs and Nurse Practitioners with estrogen replenishment options-ORTHO-EST(r) Tablets (estropipate) and Esclim(tm) (estradiol transdermal system). The Consumer Business is responsible for Daily Difference(tm) dietary supplements, developed in consultation with Tufts University School of Nutrition Science and Policy, and the Company's line of self-care products available through its As We Change(r) national mail order catalog and Internet retailer, www.aswechange.com. Trialogue(tm), the Corporate Marketing Division, is responsible for providing access to Women First's network of opinion leaders and clinicians through strategic marketing programs for sale to major pharmaceutical companies. The Company's business strategy includes the acquisition and licensing of additional prescription products that support its mission. Further information about Women First can be found online at www.womenfirst.com.